Chang JT - Search Results

1

FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer.

Hollier BG, Tinnirello AA, Werden SJ, Evans KW, Taube JH, Sarkar TR, Sphyris N, Shariati M, Kumar SV, Battula VL, Herschkowitz JI, Guerra R, Chang JT, Miura N, Rosen JM, Mani SA. Hollier BG, et al. Among authors: chang jt. Cancer Res. 2013 Mar 15;73(6):1981-92. doi: 10.1158/0008-5472.CAN-12-2962. Epub 2013 Feb 1. Cancer Res. 2013. PMID: 23378344 Free PMC article.

2

Utilization of pathway signatures to reveal distinct types of B lymphoma in the Emicro-myc model and human diffuse large B-cell lymphoma.

Mori S, Rempel RE, Chang JT, Yao G, Lagoo AS, Potti A, Bild A, Nevins JR. Mori S, et al. Among authors: chang jt. Cancer Res. 2008 Oct 15;68(20):8525-34. doi: 10.1158/0008-5472.CAN-08-1329. Cancer Res. 2008. PMID: 18922927 Free PMC article.

3

Using a stem cell-based signature to guide therapeutic selection in cancer.

Shats I, Gatza ML, Chang JT, Mori S, Wang J, Rich J, Nevins JR. Shats I, et al. Among authors: chang jt. Cancer Res. 2011 Mar 1;71(5):1772-80. doi: 10.1158/0008-5472.CAN-10-1735. Epub 2010 Dec 17. Cancer Res. 2011. PMID: 21169407 Free PMC article.

4

Sheep, wolf, or werewolf: cancer stem cells and the epithelial-to-mesenchymal transition.

Chang JT, Mani SA. Chang JT, et al. Cancer Lett. 2013 Nov 28;341(1):16-23. doi: 10.1016/j.canlet.2013.03.004. Epub 2013 Mar 14. Cancer Lett. 2013. PMID: 23499890 Free PMC article. Review.

5

Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties.

Taube JH, Malouf GG, Lu E, Sphyris N, Vijay V, Ramachandran PP, Ueno KR, Gaur S, Nicoloso MS, Rossi S, Herschkowitz JI, Rosen JM, Issa JP, Calin GA, Chang JT, Mani SA. Taube JH, et al. Among authors: chang jt. Sci Rep. 2013;3:2687. doi: 10.1038/srep02687. Sci Rep. 2013. PMID: 24045437 Free PMC article.

6

p38 MAPK inhibits breast cancer metastasis through regulation of stromal expansion.

Hong B, Li H, Zhang M, Xu J, Lu Y, Zheng Y, Qian J, Chang JT, Yang J, Yi Q. Hong B, et al. Among authors: chang jt. Int J Cancer. 2015 Jan 1;136(1):34-43. doi: 10.1002/ijc.28958. Epub 2014 May 16. Int J Cancer. 2015. PMID: 24806617 Free PMC article.

7

A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype.

Cheng Q, Chang JT, Gwin WR, Zhu J, Ambs S, Geradts J, Lyerly HK. Cheng Q, et al. Among authors: chang jt. Breast Cancer Res. 2014 Jul 25;16(4):407. doi: 10.1186/s13058-014-0407-9. Breast Cancer Res. 2014. PMID: 25060555 Free PMC article.

8

GD3 synthase regulates epithelial-mesenchymal transition and metastasis in breast cancer.

Sarkar TR, Battula VL, Werden SJ, Vijay GV, Ramirez-Peña EQ, Taube JH, Chang JT, Miura N, Porter W, Sphyris N, Andreeff M, Mani SA. Sarkar TR, et al. Among authors: chang jt. Oncogene. 2015 Jun 4;34(23):2958-67. doi: 10.1038/onc.2014.245. Epub 2014 Aug 11. Oncogene. 2015. PMID: 25109336 Free PMC article.

9

CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression.

Li L, Liu C, Amato RJ, Chang JT, Du G, Li W. Li L, et al. Among authors: chang jt. Oncotarget. 2014 Nov 15;5(21):10840-53. doi: 10.18632/oncotarget.2535. Oncotarget. 2014. PMID: 25333262 Free PMC article.

10

A novel embryonic plasticity gene signature that predicts metastatic competence and clinical outcome.

Soundararajan R, Paranjape AN, Barsan V, Chang JT, Mani SA. Soundararajan R, et al. Among authors: chang jt. Sci Rep. 2015 Jun 30;5:11766. doi: 10.1038/srep11766. Sci Rep. 2015. PMID: 26123483 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

740 results

Search Page

Filters